Akero Therapeutics, Inc.
AKRO
Revenue
0.00
0.000.00%
-Assets
865.04M
▼-47.20M▼-5.17%
3 Months ChangeLiabilities
66.98M
▲986.00k▲1.49%
3 Months ChangeFree Cash Flow
-70.95M
▼-70.95M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-09
Form 10-Q
ID: 0000950170-24-094347
2024-08-09
Form 8-K
ID: 0001193125-24-197477
2024-06-12
Form 8-K
ID: 0001193125-24-160069
2024-05-10
Form 10-Q
ID: 0000950170-24-057458
2024-05-10
Form 8-K
ID: 0001193125-24-135733
2024-03-18
Form 8-K
ID: 0001193125-24-070191
2024-03-06
Form 8-K
ID: 0001193125-24-060883
2024-03-04
Form 8-K
ID: 0001193125-24-056901
2024-02-29
Form 8-K
ID: 0001193125-24-051775
2023-12-18
Form 8-K
ID: 0001193125-23-297097